Pds Biotechnology Corp (PDSB) — 10-Q Filings
All 10-Q filings from Pds Biotechnology Corp. Browse 2 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (2)
-
PDS Biotech Narrows Loss, Cash Drains Amid R&D Cuts
— Aug 13, 2025 Risk: high
PDS Biotechnology Corp (PDSB) reported a net loss of $17,923,175 for the six months ended June 30, 2025, a slight improvement from the $18,931,374 net loss in t -
PDS Biotechnology Files Q1 2025 10-Q
— May 14, 2025 Risk: medium
PDS Biotechnology Corp. filed its 10-Q for the period ending March 31, 2025. The company, formerly Edge Therapeutics, Inc., is based in Princeton, NJ. The filin
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX